Joint webinar with Labcorp: Imaging in oncology trials can it help to make “go or no go” decisions

This webinar organized by Labcorp Drug Development and Median Technologies discuss modern imaging biomarkers covering the most important cancer hallmarks such as cell death, metabolism, vascularity, and hypoxia, and explain how they could be used in oncology trials for early response assessment and disease management.
Our presenter panel includes high level experts:
• Pr Laure Fournier, Academic Radiologist, AP-HP, Assistance Publique-Hôpitaux de Paris, France
• Dr Ravi Karra, M.D, Senior Medical Director Oncology, Labcorp Drug Development
• Dr Yan Liu, Chief Medical Officer, Median Technologies